Hypertension is highly prevalent in patients with diabetic nephropathy. Diabetic nephropathy
is the leading cause of CKD and end-stage kidney disease in the United States. The etiology …

Diabetic nephropathy is the leading cause of end-stage renal disease in the United States.
The progression of kidney disease in patients with diabetes can take many years, and …

Diabetic nephropathy affects 30–40% of people with diabetes, and is the leading cause of
end‐stage kidney disease. The current treatment paradigm relies on early detection …

Nephropathy remains a major cause of morbidity and a key determinant of mortality in
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …

Type 2 diabetes is the most common cause of CKD and ESRD in the United States and the
Western world. Hypertension is prevalent in this cohort, and control of blood pressure is …

Discussion This woman with diabetes, hypertension, LVH, and diabetic nephropathy has a
risk for death from myocardial infarction (MI) or stroke that is at least as high as that for …

As the increasing prevalence of diabetes reaches epidemic proportions worldwide, diabetic
nephropathy and associated end‐stage renal failure will be an unavoidable major health …

Cardiovascular disease plays a major role in the morbidity and mortality of patients with
diabetes mellitus. In turn, hypertension is a major risk factor for cardiovascular disease, and …

Diabetic nephropathy (DN) is a well-described complication of diabetes mellitus and the
leading cause of end stage renal disease (ESRD). Although increased albuminuria has …

The incidence and prevalence of type 2 diabetes are increasing; 1, 2 it is projected that the
total number of people with diabetes will rise from 171 million in 2000 to 366 million by …